A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

Wilfried De Backer1 Department of Respiratory Medicine, University of Antwerp, Antwerp, Belgium, [email protected]Correspondence[email protected]

Jan De Backer2 FLUIDDA, Los Angeles, CA, USA

Wim Vos3 FLUIDDA, Kontich, Belgium

Ilse Verlinden3 FLUIDDA, Kontich, Belgium

Cedric Van Holsbeke3 FLUIDDA, Kontich, Belgium

Johan Clukers1 Department of Respiratory Medicine, University of Antwerp, Antwerp, Belgium, [email protected]

Bita Hajian1 Department of Respiratory Medicine, University of Antwerp, Antwerp, Belgium, [email protected]

Shahid Siddiqui4 AstraZeneca, Gaithersburg, MD, USA

Martin Jenkins5 AstraZeneca, Cambridge, UK

Colin Reisner4 AstraZeneca, Gaithersburg, MD, USA;6 Pearl – A member of the AstraZeneca Group, Morristown, NJ, USA

Ubaldo J Martin4 AstraZeneca, Gaithersburg, MD, USA

Your download is now in progress and you may close this window